Retatrutide Research Supplier in Delhi, India
Research Use Only: All compounds supplied by Aarise Healthcare are strictly for laboratory research and scientific investigation. Not intended for human consumption, therapeutic use, or clinical application. All purchases must comply with applicable local laws and regulations.
Aarise Healthcare supplies Retatrutide (CAS: 2381247-90-9) to research institutions, universities, and laboratories in Delhi, India. Our Retatrutide is supplied at 98%+ purity for triple GIP/GLP-1/glucagon receptor research.
Retatrutide Research Supply Specifications — Delhi
| Compound | Retatrutide |
| CAS Number | 2381247-90-9 |
| Purity | 98%+ (HPLC verified) |
| Form | Lyophilised powder |
| Storage | -20°C, protected from light |
| MOQ | 5mg (research quantities) |
| Delivery to Delhi | 2-4 business days |
| Documentation | CoA, HPLC report, MS data |
Research Applications of Retatrutide
Retatrutide is used in triple GIP/GLP-1/glucagon receptor research. Research institutions in Delhi use this compound for preclinical studies and laboratory investigations under appropriate research protocols.
Why Research Institutions in Delhi Source from Aarise Healthcare
- WHO-GMP certified manufacturing facility
- 98%+ purity with independent third-party CoA
- Temperature-controlled shipping to Delhi
- Dedicated research supply team
- Bulk quantities available for ongoing research programmes
- Fast 2-4 day delivery across India including Delhi
Related Peptides Available in Delhi
Semaglutide in Delhi | Tirzepatide in Delhi | Liraglutide in Delhi | Mazdutide in Delhi
Retatrutide Research Supply — Other Indian Cities
Retatrutide in Mumbai | Retatrutide in Hyderabad | Retatrutide in Bangalore | Retatrutide in Chennai
Request Retatrutide for your Delhi research facility: Contact our research supply team with your institution details and quantity requirements. We respond within 24 hours with pricing and availability.
